POPULARITY
Katrine Bosley is former CEO of Editas Medicines and Avila Therapeutics. She discusses growing up in Ohio, her first job in biotech (as an administrative assistant) and why her five years at CRISPR company Editas felt more like 1,000. This episode is part of Nature Biotechnology's focus issue on translating the CRISPR technology. See acast.com/privacy for privacy and opt-out information.
Over the next several weeks Distillations will be talking to people who have special insight into the coronavirus crisis—biomedical researchers, physicians, public health experts, and historians. In this episode our producer Rigberto Hernandez talks with Katrine Bosley, who has worked in the biotech industry for more than 30 years. Until recently she was the CEO of Editas Medicine, a company that focuses on a gene-editing technology known as CRISPR. She’s now on the board of the Massachusetts Eye and Ear Hospital and is advising the facility on its quest to create a COVID-19 vaccine. She tells us how CRISPR can be used to make faster diagnostic tests and how the hospital in Boston is creating a vaccine using a gene therapy method. “One of the things that’s important for all of us competing against this virus is to have a lot of technologically different strategies to try to make a vaccine.” Credits Hosts: Elisabeth Berry Drago, Alexis Pedrick Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Researcher: Jessica Wade Audio Engineer: Jonathan Pfeffer
On this week's Tech Nation, Moira speaks with … Ray Dalio, the founder and co-chair of Bridgewater Associates, which he founded 40 years ago in his 2 bedroom apartment. Today it is recognized as the world's largest hedge fund. His mental processes, his values and how he sees the world are all part of his book “Principles: Life and Work”. Then on Tech Nation Health, the biotechnology of CRISPR. We hear from Katrine Bosley, the President & CEO of Editas Medicine. This is a new kind of therapeutic.
On this week’s Tech Nation, Moira speaks with … Ray Dalio, the founder and co-chair of Bridgewater Associates, which he founded 40 years ago in his 2 bedroom apartment. Today it is recognized as the world’s largest hedge fund. His mental processes, his values and how he sees the world are all part of his book “Principles: Life and Work”. Then on Tech Nation Health, the biotechnology of CRISPR. We hear from Katrine Bosley, the President & CEO of Editas Medicine. This is a new kind of therapeutic.
On Tech Nation Health, the biotechnology of CRISPR. We hear from Katrine Bosley, the President & CEO of Editas Medicine. This is a new kind of therapeutic.
On Tech Nation Health, the biotechnology of CRISPR. We hear from Katrine Bosley, the President & CEO of Editas Medicine. This is a new kind of therapeutic.
Ep. 2 of The Long Run With Luke Timmerman. Interview with Katrine Bosley, CEO of Editas Medicine.